Related Experiment Video
Updated: Aug 12, 2025

03:40
Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
Published on: December 8, 2023
1.2K
Evolution of Hematopoietic Stem Cell Transplant Programs in Malaysia
Norashikin Saidon1, Nur Adila Anuar2, Chang Kian Meng3
1Faculty of Medicine, Sungai Buloh, Universiti Teknologi MARA, Malaysia.
Blood Cell Therapy
|January 30, 2023
Summary
Hematopoietic stem cell transplantation (HSCT) in Malaysia has advanced significantly since 1987, offering cures for blood diseases. Despite challenges, 13 hospitals now provide HSCT services, with nearly 3,600 procedures performed by 2015.
Area of Science:
- Hematology
- Transplantation Medicine
- Public Health Policy
Background:
- Hematopoietic stem cell transplantation (HSCT) is a crucial treatment for various hematological diseases.
- Malaysia has established HSCT services across public and private healthcare sectors.
- The development of HSCT in Malaysia reflects its growing medical capabilities.
Purpose of the Study:
- To chronicle the historical progression and development of HSCT in Malaysia.
- To highlight the evolution of HSCT services since the first pediatric case in 1987.
- To identify and briefly discuss challenges encountered in Malaysian HSCT programs.
Main Methods:
- Historical review of HSCT milestones in Malaysia.
- Analysis of HSCT service provision across different hospital types (government, teaching, private).
- Data compilation of HSCT procedures performed up to 2015.
Main Results:
- The first pediatric allogeneic HSCT was performed in 1987, followed by the first adult HSCT in 1993.
- Currently, 13 hospitals nationwide offer HSCT services.
- By 2015, Malaysia had performed 1,987 allogeneic and 1,648 autologous HSCT procedures.
Conclusions:
- Malaysia has made substantial progress in establishing and expanding HSCT services.
- The availability of HSCT in Malaysia has grown significantly, serving both pediatric and adult populations.
- Ongoing challenges in HSCT require continued attention for further development.
Related Concept Videos
Bone Marrow Sampling and Transplants
385
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
385
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Multipotency of Hematopoietic Stem Cells
3.2K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.2K

